Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. News archives / 新聞典藏
  3. 焦點新聞
  4. 8/11「從實驗室到市場」北醫×羅麗芬控股×訊聯生技啟動研發轉譯新篇章
 
  • Details
Options

8/11「從實驗室到市場」北醫×羅麗芬控股×訊聯生技啟動研發轉譯新篇章

Type
newspaper
Date Issued
2025-08-11
Author(s)
秘書處/SL
Subjects
焦點新聞
Abstract
位於全台唯一結合醫學大學、醫學中心與生醫產業的臺北醫學大學雙和生醫園區,再度成功展現其推動產學合作與技術落地的實力。北醫攜手羅麗芬控股與訊聯生技,選在父親節8月8日當天舉行「聯合創新研發成果暨新品發表記者會」,正式發表紅球薑抗老保養系列產品,完整體現「研發-轉譯-驗證-商品化」的一站式創新生態鏈結,成為台灣醫療研發轉譯最具代表性的示範案例之一。
URI
https://203.71.86.71/handle/123456789/43352
File(s)
Loading...
Thumbnail Image
Name

attachment.pdf

Size

306.2 KB

Format

Adobe PDF

Checksum

(MD5):213ed62af255968f065914eddf39c30c

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback